tirzepatide news today Why new weight loss drugs are out of reach for millions of older Americans Lilly's Mounjaro tops other GLP-1s

Benedict, C

This is a magnitude of weight loss that was previously associated only with bariatric surgery

Industry expert Kim Durgan, senior manager of government affairs and policy at Jubilant HollisterStier, highlighted in a recent interview with Powder & Bulk Solids that scaling up production is no simple feat

We talked to doctors to answer the question of why youre not losing weight on semaglutide, plus how to maximize your results

A multicenter, randomized, double-blind, multiple dose-escalation study showed that after 4 weeks of treatment of PEX-168 with different doses, the weight decreased by -0.8-1.8kg

The Pharmaceutical Benefits Advisory Committee (PBAC) recommended tirzepatide an injectable GLP-1 medication sold as Mounjaro be subsidised for adults with "inadequately controlled" type 2 diabetes